Screening for Swallowing Problems in Patients Following Prolonged Intubation: Validation of the Toronto Bedside Swallowing Screening Test (TOR-BSST©)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Despite medical advances, half of the patients admitted to hospital for recovery from acute illness, injury or surgery have swallowing difficulties and those requiring tubes for breathing support are at even greater risk. Difficulties with swallowing decrease patients' quality of life, prolong their hospital stay, as well as lead to medical complications such as pneumonia, malnutrition and death. Presently, there is no screening test for swallowing difficulties in patients who have required respiratory support. Screening will allow for early detection of swallowing problems which is important to prevent serious complications, such as pneumonia. This research will determine the accuracy of a new screening test, the Toronto Bedside Swallowing Screening Test (TOR-BSST©) previously tested with stroke patients, to predict the presence of swallowing difficulties in patients who have required breathing support for longer than 48 hours. The investigators will enroll 100 patients from the intensive care medical surgical units at the University Health Network. The findings from this research will help identify those patients with swallowing problems earlier than it is currently possible. Once identified, at risk patients will be referred to a speech language pathologist swallowing expert for more comprehensive testing; thereby, decreasing their risk of experiencing serious complications, such as pneumonia, secondary to swallowing problems.
| Condition | Intervention |
|---|---|
|
Dysphagia |
Other: Toronto Bedside Swallowing Screening Test (TOR-BSST©) Procedure: Videofluoroscopic Swallow Study |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
- Validity of the TOR-BSST© [ Time Frame: 24 hours ] [ Designated as safety issue: No ]The validity of the TOR-BSST© will be measured using sensitivity, specificity, likelihood ratios, positive predictive value (PPV), and negative predictive value (NPV). Results of the videofluoroscopic assessment of swallowing will be used as the gold standard comparison.
- Inter-rater reliability of the TOR-BSST© [ Time Frame: 24 hours ] [ Designated as safety issue: No ]Inter-rater reliability will be calculated using the intraclass correlation coefficient (ICC).
- Estimation of the incidence of dysphagia in adult acute patients following prolonged intubation [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
- Description of the impairment characteristics of dysphagia in adult acute patients following prolonged intubation [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 100 |
| Study Start Date: | May 2011 |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Med/Surg ICU Inpatients, Intubated ≥ 48 hours |
Other: Toronto Bedside Swallowing Screening Test (TOR-BSST©)
All enrolled patients will be screened for dysphagia by two blinded screeners using the TOR-BSST©.
Procedure: Videofluoroscopic Swallow Study
All enrolled patients will undergo a videofluoroscopic assessment of swallowing within 24 hours of being screened with the TOR-BSST©.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Med/Surg ICU inpatients who have received endotracheal intubation lasting 48 hours or longer
Inclusion Criteria:
- Adults 18+ years
- Inpatient at University Health Network, in any of the medical-surgical intensive care units, regardless of disease type, comorbidities or previous medical history
- Received endotracheal intubation lasting 48 hours or longer
Exclusion Criteria:
- History of one or more of the following: neurological disorder, surgery to the head or neck, previous oropharyngeal dysphagia, tracheotomy in situ or dementia
Contacts and Locations| Contact: Trixie Reichardt, MHSc | 416-603-5800 ext 3913 | trixie.reichardt@uhnresearch.ca |
| Contact: Rosemary Martino, PhD | 416-946-8644 | rosemary.martino@utoronto.ca |
| Canada, Ontario | |
| University Health Network | Recruiting |
| Toronto, Ontario, Canada, M5G 2C4 | |
| Contact: Rosemary Martino, PhD 416-946-8644 rosemary.martino@utoronto.ca | |
| Principal Investigator: Rosemary Martino, PhD | |
| Principal Investigator: | Rosemary Martino, PhD | University of Toronto / University Health Network |
More Information
Additional Information:
Publications:
| Responsible Party: | University Health Network, Toronto |
| ClinicalTrials.gov Identifier: | NCT01411306 History of Changes |
| Other Study ID Numbers: | 110957 |
| Study First Received: | August 4, 2011 |
| Last Updated: | June 18, 2012 |
| Health Authority: | Canada: Canadian Institutes of Health Research |
Additional relevant MeSH terms:
|
Deglutition Disorders Esophageal Diseases Gastrointestinal Diseases |
Digestive System Diseases Pharyngeal Diseases Otorhinolaryngologic Diseases |
ClinicalTrials.gov processed this record on May 19, 2013